Key Events This Week
2 Mar: Valuation shift signals price attractiveness change
4 Mar: Technical downgrade triggers bearish momentum
6 Mar: Stock rebounds strongly to close at Rs.74.06 (+4.43%)
Mar 24
BSE+NSE Vol: 59.32 lacs

The Sensex declined by 1.02% on 24 Mar 2026, yet IOL Chemicals & Pharmaceuticals Ltd surged 7.81%, reaching an intraday high of Rs 78.14. This 7.2 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
IOL Chemicals & Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from Hold to Sell by MarketsMOJO, coupled with deteriorating moving averages and bearish MACD readings, suggests increasing downside pressure amid a challenging market environment.
Read full news article
IOL Chemicals & Pharmaceuticals Ltd has experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a recent uptick in price, key technical indicators such as MACD and moving averages continue to signal caution, reflecting a complex landscape for investors in this small-cap pharmaceutical player.
Read full news article
IOL Chemicals & Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
IOL Chemicals & Pharmaceuticals Ltd has seen a marked shift in its valuation parameters, moving from fair to very expensive territory, prompting a downgrade in its investment grade. Despite a recent surge in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now exceed historical and peer averages, raising questions about its price attractiveness amid sector volatility.
Read full news article
IOL Chemicals & Pharmaceuticals Ltd recorded a robust intraday performance on 18 Mar 2026, surging 7.02% to touch a day’s high of Rs 72.99. This marks a notable rebound after five consecutive days of decline, significantly outperforming the Pharmaceuticals & Biotechnology sector and the broader Sensex index.
Read full news article
IOL Chemicals & Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend across multiple timeframes. The stock’s recent price action, combined with deteriorating moving averages and momentum oscillators, suggests increasing downside pressure amid a challenging market backdrop for the Pharmaceuticals & Biotechnology sector.
Read full news article
2 Mar: Valuation shift signals price attractiveness change
4 Mar: Technical downgrade triggers bearish momentum
6 Mar: Stock rebounds strongly to close at Rs.74.06 (+4.43%)